Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 110
Filter
1.
J Basic Microbiol ; 61(3): 230-240, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33491793

ABSTRACT

A bacterium designated as strain STP14 was isolated from a sewage treatment plant and identified as Acinetobacter calcoaceticus based on 16S ribosomal RNA gene sequencing. Strain STP14 exhibited resistance to several metals such as mercury, cobalt, copper, nickel, lead, and cadmium. Among these metals, the bacterium showed maximum resistance to cadmium in concentration up to 1200 mg/L. The antimicrobial susceptibility test of A. calcoaceticus strain STP14 showed coresistance to all tested antibiotics except tigecycline and chloramphenicol for which 16 ± 1- and 15 ± 1-mm zone of inhibition was observed, respectively. The protein pattern of the crude cellular extract revealed substantial differences in protein bands of untreated control and cadmium treated A. calcoaceticus strain STP14 suggesting variable protein expression under cadmium stress. Metals and antibiotic resistance are increasing phenomenon and universal concern of public health. This study improves our understanding regarding the bacterial coresistance against metals and antibiotics and the possible emergence of multidrug resistance due to selective pressure and coselection in the metal polluted sewage sludge.


Subject(s)
Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/genetics , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Metals, Heavy/toxicity , Sewage/microbiology , Acinetobacter calcoaceticus/isolation & purification , Metals, Heavy/analysis , Microbial Sensitivity Tests , Sewage/chemistry , Water Purification/methods
2.
Article in English | IBECS | ID: ibc-199908

ABSTRACT

INTRODUCTION: Acinetobacter is a genus that comprises a group of opportunistic pathogens responsible for a variety of nosocomial infections. The Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex includes some species of clinical importance, mainly A. baumannii, A. pittii and A. nosocomialis, which share phenotypic similarities that make it very difficult to distinguish between them using a phenotypic approach. The aim of this study was to evaluate two commercial matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems for the identification of different Acinetobacter species, with a special focus among those belonging to the Acb complex. METHODS: One hundred and fifty-six Acinetobacter spp. clinical strains, identified by amplified ribosomal DNA restriction analysis (ARDRA) and rpoB gene sequencing, were analysed by two different MALDI-TOF systems. RESULTS: Considering only the 144 strains of the Acb complex evaluated in this study, the Vitek-MS(TM) and Microflex LT(TM) systems correctly identified 129 (89.6%) and 143 (99.3%) strains, respectively. CONCLUSION: After analysing 156 strains belonging to Acinetobacter spp., both Vitek-MS(TM) and Microflex LT(TM) proved to be rapid and accurate systems for the identification of Acb complex species showing a good correlation. However, both manufacturers should improve their databases to include new species in them


INTRODUCCIÓN: Acinetobacter es un género que comprende un grupo de patógenos oportunistas responsables de varias infecciones nosocomiales. El complejo Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) reúne algunas especies de importancia clínica, principalmente A. baumannii, A. pittii y A. nosocomialis, que comparten similitudes fenotípicas que hacen muy difícil poder discriminar entre ellas utilizando un enfoque fenotípico. El objetivo de este estudio fue evaluar 2 sistemas comerciales de espectrometría de masas de ionización por láser asistido con una matriz (MALDI-TOF MS) para la identificación de diferentes especies de Acinetobacter, con un enfoque especial entre los que pertenecen al complejo Acb. MÉTODOS: Analizamos 156 cepas clínicas de Acinetobacter spp., identificadas mediante análisis de restricción de ADN ribosomal amplificado (ARDRA) y secuenciación del gen rpoB, por 2 sistemas diferentes de MALDI-TOF. RESULTADOS: Teniendo en cuenta solo las 144 cepas del complejo Acb evaluadas en este estudio, los sistemas Vitek(R) MS y Microflex(R) LT identificaron correctamente 129 (89,6%) y 143 (99,3%) cepas, respectivamente. CONCLUSIÓN: Después de analizar 156 cepas pertenecientes a Acinetobacter spp., Vitek(R) MS y Microflex(R) LT demostraron ser sistemas rápidos y precisos para la identificación de especies del complejo Acb mostrando una buena correlación. Sin embargo, ambos fabricantes deberían mejorar sus bases de datos incluyendo nuevas especies en ellas


Subject(s)
Humans , Acinetobacter baumannii/isolation & purification , Acinetobacter Infections/diagnosis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Acinetobacter Infections/microbiology , DNA, Bacterial/analysis , Bacteriological Techniques , DNA, Ribosomal/analysis , Acinetobacter calcoaceticus/isolation & purification
3.
Anal Chem ; 92(24): 16051-16057, 2020 12 15.
Article in English | MEDLINE | ID: mdl-33211958

ABSTRACT

Clinical identification of the pathogenic bacterium Moraxella catarrhalis in cultures relies on the detection of bacterial butyrate esterase (C4-esterase) using a coumarin-based fluorogenic substrate, 4-methylumbelliferyl butyrate. However, this classical probe may give false-positive responses because of its poor stability and lack of specificity. Here, we report a new colorimetric and fluorogenic probe design employing a meso-ester-substituted boron dipyrromethene (BODIPY) dye for the specific detection of C4-esterase activity expressed by M. catarrhalis. This new probe has resistance to nonspecific hydrolysis that is far superior to the classical probe and also selectively responds to esterase with rapid colorimetric and fluorescence signal changes and large "turn-on" ratios. The probe was successfully applied to the specific detection of M. catarrhalis with high sensitivity.


Subject(s)
Acinetobacter calcoaceticus/enzymology , Acinetobacter calcoaceticus/isolation & purification , Carboxylic Ester Hydrolases/metabolism , Colorimetry/methods , Fluorescent Dyes/metabolism , Boron Compounds/chemistry , Boron Compounds/metabolism , Fluorescent Dyes/chemistry , Limit of Detection , Time Factors
4.
BMC Biotechnol ; 20(1): 39, 2020 07 25.
Article in English | MEDLINE | ID: mdl-32711499

ABSTRACT

BACKGROUND: With the high demand for diesel across the world, environmental decontamination from its improper usage, storage and accidental spills becomes necessary. One highly environmentally friendly and cost-effective decontamination method is to utilize diesel-degrading microbes as a means for bioremediation. Here, we present a newly isolated and identified strain of Acinetobacter calcoaceticus ('CA16') as a candidate for the bioremediation of diesel-contaminated areas. RESULTS: Acinetobacter calcoaceticus CA16 was able to survive and grow in minimal medium with diesel as the only source of carbon. We determined through metabolomics that A. calcoaceticus CA16 appears to be efficient at diesel degradation. Specifically, CA16 is able to degrade 82 to 92% of aliphatic alkane hydrocarbons (CnHn + 2; where n = 12-18) in 28 days. Several diesel-degrading genes (such as alkM and xcpR) that are present in other microbes were also found to be activated in CA16. CONCLUSIONS: The results presented here suggest that Acinetobacter strain CA16 has good potential in the bioremediation of diesel-polluted environments.


Subject(s)
Acinetobacter calcoaceticus/genetics , Acinetobacter calcoaceticus/isolation & purification , Acinetobacter calcoaceticus/metabolism , Gasoline , Genomics , Soil Microbiology , Acinetobacter calcoaceticus/classification , Alkanes , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Biodegradation, Environmental , Canada , Carbon/metabolism , Gene Expression Regulation, Bacterial , Hydrocarbons , Metabolomics , Phylogeny , Soil
5.
Int J Mol Sci ; 21(2)2020 Jan 16.
Article in English | MEDLINE | ID: mdl-31963214

ABSTRACT

The mechanisms of action of the complex including entomopathogenic nematodes of the genera Steinernema and Heterorhabditis and their mutualistic partners, i.e., bacteria Xenorhabdus and Photorhabdus, have been well explained, and the nematodes have been commercialized as biological control agents against many soil insect pests. However, little is known regarding the nature of the relationships between these bacteria and the gut microbiota of infected insects. In the present study, 900 bacterial isolates that were obtained from the midgut samples of Melolontha melolontha larvae were screened for their antagonistic activity against the selected species of the genera Xenorhabdus and Photorhabdus. Twelve strains exhibited significant antibacterial activity in the applied tests. They were identified based on 16S rRNA and rpoB, rpoD, or recA gene sequences as Pseudomonas chlororaphis, Citrobacter murliniae, Acinetobacter calcoaceticus, Chryseobacterium lathyri, Chryseobacterium sp., Serratia liquefaciens, and Serratia sp. The culture filtrate of the isolate P. chlororaphis MMC3 L3 04 exerted the strongest inhibitory effect on the tested bacteria. The results of the preliminary study that are presented here, which focused on interactions between the insect gut microbiota and mutualistic bacteria of entomopathogenic nematodes, show that bacteria inhabiting the gut of insects might play a key role in insect resistance to entomopathogenic nematode pressure.


Subject(s)
Larva/microbiology , Photorhabdus/genetics , Photorhabdus/isolation & purification , Xenorhabdus/genetics , Xenorhabdus/isolation & purification , Acinetobacter calcoaceticus/genetics , Acinetobacter calcoaceticus/isolation & purification , Animals , Chryseobacterium/genetics , Chryseobacterium/isolation & purification , Citrobacter/genetics , Citrobacter/isolation & purification , Gastrointestinal Microbiome/genetics , Gastrointestinal Microbiome/physiology , Pseudomonas chlororaphis/genetics , Pseudomonas chlororaphis/isolation & purification , RNA, Ribosomal, 16S/genetics , Serratia liquefaciens/genetics , Serratia liquefaciens/isolation & purification , Symbiosis/genetics , Symbiosis/physiology
6.
Protein Expr Purif ; 160: 36-44, 2019 08.
Article in English | MEDLINE | ID: mdl-30926462

ABSTRACT

Xanthine oxidase (EC 1.17.3.2) is a key enzyme of purine metabolism and has potential applications in food and pharmaceutical industries. In the present study, a new bacterial source of xanthine oxidase i.e. Acinetobacter calcoaceticus RL2-M4 with high oxidase activity was isolated from soil. The culture conditions were optimized with one variable at a time (OVAT) and response surface methodology (RSM) approaches included: a minimal salt medium (MSM) of pH 7.0 supplemented with 0.8% yeast extract, 8.5 mM xanthine and incubation at 30 °C for 24 h. Under these culture conditions 11.57 fold increase in the production of this enzyme was achieved. The enzyme was purified from A. calcoaceticus RL2-M4 using anion exchange chromatography to 8.18 fold with 31% yield and specific activity of 4.58 U/mg protein. SDS-PAGE analysis of the purified enzyme revealed that it was homodimer of 95 kDa and its native molecular mass was estimated to be 190 kDa. This enzyme was found to be stable at 35 °C for 5 h. The purified xanthine oxidase of A. calcoaceticus RL2-M4 had Km 0.3 mM and Vmax 5.8 U/mg protein using xanthine as substrate. The activity and stability characteristic of xanthine oxidase of A. calcoaceticus RL2-M4 makes it a potentially good enzyme for industrial applications.


Subject(s)
Acinetobacter calcoaceticus/enzymology , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Xanthine Oxidase/chemistry , Xanthine Oxidase/isolation & purification , Acinetobacter calcoaceticus/chemistry , Acinetobacter calcoaceticus/genetics , Acinetobacter calcoaceticus/isolation & purification , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Chromatography, Ion Exchange , Dimerization , Electrophoresis, Polyacrylamide Gel , Enzyme Stability , Hydrogen-Ion Concentration , Kinetics , Molecular Weight , Soil Microbiology , Temperature , Xanthine Oxidase/genetics , Xanthine Oxidase/metabolism
7.
Molecules ; 24(1)2019 Jan 04.
Article in English | MEDLINE | ID: mdl-30621147

ABSTRACT

In recent years, several efforts have been made to develop quick and low cost bacterial identification methods. Genotypic methods, despite their accuracy, are laborious and time consuming, leaving spectroscopic methods as a potential alternative. Mass and infrared spectroscopy are among the most reconnoitered techniques for this purpose, with Raman having been practically unexplored. Some species of the bacterial genus Acinetobacter are recognized as etiological agents of nosocomial infections associated with high rates of mortality and morbidity, which makes their accurate identification important. The goal of this study was to assess the ability of Raman spectroscopy to discriminate between 16 Acinetobacter species belonging to two phylogroups containing taxonomically closely related species, that is, the Acinetobacter baumannii-Acinetobacter calcoaceticus complex (six species) and haemolytic clade (10 species). Bacterial spectra were acquired without the need for any sample pre-treatment and were further analyzed with multivariate data analysis, namely partial least squares discriminant analysis (PLSDA). Species discrimination was achieved through a series of sequential PLSDA models, with the percentage of correct species assignments ranging from 72.1% to 98.7%. The obtained results suggest that Raman spectroscopy is a promising alternative for identification of Acinetobacter species.


Subject(s)
Acinetobacter baumannii/chemistry , Acinetobacter calcoaceticus/chemistry , Cross Infection/diagnosis , Spectrum Analysis, Raman , Acinetobacter baumannii/classification , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/isolation & purification , Bacteriological Techniques , Classification , Cross Infection/microbiology , Humans
8.
J Crit Care ; 49: 124-128, 2019 02.
Article in English | MEDLINE | ID: mdl-30419545

ABSTRACT

INTRODUCTION: Acinetobacter species treatment often represents a challenge. The main objective of this study is identify predictors of ICU mortality in patients submitted to mechanical ventilation (MV). MATERIALS AND METHODS: Retrospective cohort study. Patients with MV > 48 h who developed a respiratory tract positive culture for Acinetobacter were included, and distinguished among colonized, ventilator-associated pneumonia (VAP) or ventilator-associated tracheobronchitis (VAT) patients. Primary outcome was ICU mortality. RESULTS: 153 patients were in MV and presented positive culture for Acinetobacter calcoaceticus-baumanii complex, 70 of them with VAP, 59 with VAT and 24 patients were colonized. The factors related to ICU mortality were VAP (OR 2.2, 95% CI 1.1-4.5) and shock at the time of diagnosis (OR 4.8, 95% CI 1.8-2.3). In multivariate analysis, only SOFA score at the time of diagnosis (OR 1.06, 95% CI 1.03-1.09) was related with ICU mortality. A paired-matched analysis was performed to assess effect of dual therapy on outcomes, and no effect was found in terms of clinical cure, ICU or hospital mortality or duration of antimicrobial therapy. CONCLUSIONS: Previous comorbidities and degree of associated organic injury seem to be more important factors in the prognosis than double antibiotic therapy in patients with Acinetobacter-related respiratory infection.


Subject(s)
Acinetobacter Infections/mortality , Intensive Care Units/statistics & numerical data , Pneumonia, Ventilator-Associated/mortality , Respiration, Artificial/adverse effects , Acinetobacter Infections/drug therapy , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/isolation & purification , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Female , Hospital Mortality , Humans , Male , Middle Aged , Pneumonia, Ventilator-Associated/drug therapy , Pneumonia, Ventilator-Associated/microbiology , Retrospective Studies
9.
JNMA J Nepal Med Assoc ; 57(220): 424-428, 2019.
Article in English | MEDLINE | ID: mdl-32335654

ABSTRACT

INTRODUCTION: Acinetobacter species are short, stout, gram-negative coccobacilli, generally considered to be a relatively low-grade pathogen. However, its resistance towards multiple classes of antibiotics through an array of resistance mechanisms including its ability to form biofilm has led to its emergence as an important pathogen in hospital settings. This study was done to determine the prevalence of biofilm former and Extended-spectrum Beta-Lactamase producer among Acinetobacter species. METHODS: A descriptive cross-sectional study was done in the clinical microbiology laboratory, Kathmandu Medical College from January to June 2019. Convenient sampling method was used. Ethical approval was taken from the Institutional Review Committee, Ref no. 2812201805. Preliminary identification followed by characterization of Acinetobacter species was done. Antibiotic susceptibility test was done using the Kirby-Bauer method following Clinical and Laboratory Standards Institute guidelines. Extended-spectrum Beta-Lactamase was detected by combined disc method and Biofilm detection was done using congo red agar method. Statistical Package for Social Sciences 16.0 version statistical software package was used for statistical analysis. Point estimate at 95% Confidence Interval was calculated along with frequencyand proportion for binarydata. RESULTS: Among 108 Acinetobacter species, 86 (79.7%) Acinetobacter calcoaceticus-A. baumannii complex was seen. Seventy-eight (72%) of the isolates were multidrug-resistant, 34 (31%) of the isolates were Extended-spectrum Beta-Lactamase producer and only 10 (9.3%) of the isolates, were biofilm producers. CONCLUSIONS: Multidrug-resistant Acinetobacter spp. with the ability to produce Extended-spectrum Beta-Lactamase is prevalent in our hospital settings. Strict compliance with infection control practices is necessary to curb its spread.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/physiology , Acinetobacter calcoaceticus/physiology , Biofilms/growth & development , beta-Lactam Resistance/physiology , Acinetobacter/isolation & purification , Acinetobacter/physiology , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/isolation & purification , Bacteremia/microbiology , Cross-Sectional Studies , Drug Resistance, Multiple/physiology , Humans , Microbial Sensitivity Tests , Nepal , Respiratory Tract Infections/microbiology , Tertiary Care Centers , Urinary Tract Infections/microbiology , beta-Lactamases/metabolism
10.
Article in English | MEDLINE | ID: mdl-29344351

ABSTRACT

Background: Carbapenem-nonsusceptible A. baumannii-calcoaceticus complex have emerged worldwide, but the epidemiology in Indonesian hospitals has not been studied. Methods: A prospective observational study was performed on the intensive care units (ICUs) of the national referral hospital in Jakarta-Indonesia, in 2013 and 2014. All consecutive adult patients admitted and hospitalized for >48 h in ICUs were included. Basic and clinical data at admission were recorded. Carbapenem-nonsusceptible A. baumannii-calcoaceticus complex from clinical cultures and standardized screening were included. Environmental niches and healthcare workers (HCWs) were also screened. PCR was used to detect carbapenemase genes, and Raman spectroscopy as well as multilocus sequence typing (MLST) for typing. Results: Of 412 included patients, 69 (16.7%) carried carbapenem-nonsusceptible A. baumannii-calcoaceticus complex on admission, and 89 (25.9%) became positive during ICU stay. The acquisition rate was 43 per 1000 patient-days at risk. Six isolates were cultured from environment and one from a HCW. Acquisition of carbapenem-nonsusceptible A. baumannii-calcoaceticus complex was associated with longer ICU stay (median interquartile range [IQR]: 11 days [5-18], adjusted hazard ratio [aHR]: 2.56 [99% confidence interval (CI):1.76-3.70]), but not with mortality (adjusted odds ratio: 1.59 [99%CI: 0.74-3.40] at the chosen level of significance). The blaOXA-23-like gene was detected in 292/318 (91.8%) isolates, including isolates from the environment and HCW. Typing revealed five major clusters. Sequence types (ST)195, ST208, ST218, ST642 as well as new STs were found. The dominant clone consisted of isolates from patients and environment throughout the study period. Conclusions: Carbapenem-nonsusceptible A. baumannii-calcoaceticus complex are endemic in this setting. Prevention requires source control and limiting transmission of strains. Trial registration: The study was retrospectively registered at www.trialregister.nl (No:5541). Candidate number: 23,527, NTR number: NTR5541, Date registered NTR: 22nd December 2015.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Acinetobacter calcoaceticus/genetics , Carbapenems/pharmacology , Intensive Care Units , Molecular Epidemiology , Referral and Consultation , Acinetobacter Infections/microbiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/isolation & purification , Adult , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , DNA, Bacterial , Drug Resistance, Bacterial/genetics , Female , Health Personnel , Humans , Indonesia/epidemiology , Male , Microbial Sensitivity Tests , Middle Aged , Multilocus Sequence Typing/methods , Polymerase Chain Reaction/methods , Prevalence , Prospective Studies , Retrospective Studies , beta-Lactamases/genetics
11.
Eur J Clin Microbiol Infect Dis ; 36(2): 219-225, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27714593

ABSTRACT

Acinetobacter baumannii is an important cause of multidrug-resistant hospital acquired infections in the world. Here, we investigate the presence of NDM-1 and other carbapenemases among carbapenem-resistant A. baumannii isolated between August 2010 and December 2014 from three large hospitals in Hanoi, Vietnam. We identified 23/582 isolates (4 %) (11 from hospital A, five from hospital B, and seven from hospital C) that were NDM-1 positive, and among them 18 carried additional carbapenemase genes, including seven isolates carrying NDM-1, IMP-1, and OXA-58 with high MICs for carbapenems. Genotyping indicated that NDM-1 carrying A. baumannii have expanded clonally in these hospitals. Five new STs (ST1135, ST1136, ST1137, ST1138, and ST1139) were identified. One isolate carried NDM-1 on a plasmid belonging to the N-repA replicon type; no NDM-1-positive plasmids were identified in the other isolates. We have shown the extent of the carbapenem resistance and the local clonal spread of A. baumannii carrying NDM-1 in these hospitals; coexistence of NDM-1 and IMP-1 is reported for the first time from Vietnam here, and this will further seriously limit future therapeutic options.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/enzymology , Acinetobacter calcoaceticus/enzymology , Bacterial Proteins/metabolism , beta-Lactamases/metabolism , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/genetics , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/genetics , Acinetobacter calcoaceticus/isolation & purification , Adolescent , Adult , Aged , Carbapenems/pharmacology , Child , Child, Preschool , Female , Genotype , Hospitals , Humans , Infant , Male , Microbial Sensitivity Tests , Middle Aged , Molecular Typing , Plasmids/analysis , Prospective Studies , Vietnam/epidemiology , Young Adult , beta-Lactam Resistance
12.
Am J Infect Control ; 44(12): 1554-1557, 2016 12 01.
Article in English | MEDLINE | ID: mdl-27742144

ABSTRACT

BACKGROUND: A tabletop-type ultraviolet C (UVC) light-emitting disinfecting device was evaluated for microbiologic effectiveness, safety, usability, and end-user satisfaction. METHODS: Three different inoculums of methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter calcoaceticus-baumannii complex strains suspended in both saline and trypticase soy broth were applied onto stainless steel carriers and electronic device surfaces in triplicate and cultured for growth after UVC disinfection. Assessments of functionality and usability were performed by biomedical and human factors engineers. End-user feedback was captured using a standardized in-use survey. RESULTS: The 54 stainless steel carriers displayed growth at inoculums as low as 102 colony forming units (CFU) when a quartz dish supplied by the manufacturer was used during UVC exposure. Without the quartz dish, 54 electronic device surfaces displayed no growth for inoculums from 102-104 CFU for all organisms suspended in saline, but lower kill rates (95.7%-100%) for organisms in broth. Several minor safety and usability issues were identified prior to clinical evaluation. In-use evaluation revealed keen user endorsement; however, suboptimal sensitivity of the machine's input sensors during sequential object insertion precluded implementation. CONCLUSIONS: Optimization of some safety and functionality parameters would improve a conceptually popular and microbiologically effective tabletop UVC disinfecting device.


Subject(s)
Colony Count, Microbial , Disinfection/instrumentation , Disinfection/methods , Electrical Equipment and Supplies/microbiology , Equipment and Supplies/microbiology , Ultraviolet Rays , Acinetobacter calcoaceticus/isolation & purification , Acinetobacter calcoaceticus/radiation effects , Humans , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/radiation effects , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/radiation effects
13.
J Small Anim Pract ; 57(11): 617-625, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27709647

ABSTRACT

BACKGROUND: Members of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex cause severe outbreaks in humans, and are increasingly reported in animals. OBJECTIVE AND METHODS: A retrospective study, describing a severe outbreak in dogs and cats caused by a multidrug resistant member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in a veterinary hospital, between July 2010 and November 2012. RESULTS: The study included 19 dogs and 4 cats. Acinetobacter calcoaceticus-Acinetobacter baumannii complex bacteria were isolated from urine (9 animals), respiratory tract (11), tissues (3) and blood (1). The most common infection-associated findings included fever, purulent discharge from endotracheal tubes, hypotension, and neutropaenia. Infections led to pneumonia, urinary tract infection, cellulitis and sepsis. Infection was transmitted in the intensive care unit, where 22 of 23 animals were initially hospitalised. The mortality rate was 70% (16 of 23 animals), and was higher in cases of respiratory infection compared to other infections. Aggressive environmental cleaning and disinfection, with staff education for personal hygiene and antisepsis, sharply decreased the infection incidence. CLINICAL SIGNIFICANCE: Health care-associated outbreaks with multidrug resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in dogs and cats are potentially highly fatal and difficult to eradicate, warranting monitoring, antiseptic techniques and judicious antibiotic use.


Subject(s)
Acinetobacter Infections/veterinary , Acinetobacter/isolation & purification , Cat Diseases/epidemiology , Disease Outbreaks/veterinary , Dog Diseases/epidemiology , Acinetobacter/classification , Acinetobacter/drug effects , Acinetobacter Infections/epidemiology , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/isolation & purification , Animals , Cat Diseases/drug therapy , Cat Diseases/microbiology , Cats , Dog Diseases/drug therapy , Dog Diseases/microbiology , Dogs , Drug Resistance, Multiple, Bacterial , Female , Hospitals, Animal , Israel/epidemiology , Male , Retrospective Studies
14.
Rev Soc Bras Med Trop ; 49(4): 433-40, 2016.
Article in English | MEDLINE | ID: mdl-27598629

ABSTRACT

INTRODUCTION: Members of the Acinetobacter genus are key pathogens that cause healthcare-associated infections, and they tend to spread and develop new antibiotic resistance mechanisms. Oxacillinases are primarily responsible for resistance to carbapenem antibiotics. Higher rates of carbapenem hydrolysis might be ascribed to insertion sequences, such as the ISAba1 sequence, near bla OXA genes. The present study examined the occurrence of the genetic elements bla OXA and ISAba1 and their relationship with susceptibility to carbapenems in clinical isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. METHODS: Isolates identified over 6 consecutive years in a general hospital in Joinville, Southern Brazil, were evaluated. The investigation of 5 families of genes encoding oxacillinases and the ISAba1 sequence location relative to bla OXA genes was conducted using polymerase chain reaction. RESULTS: All isolates presented the bla OXA-51-like gene (n = 78), and 91% tested positive for the bla OXA-23-like gene (n = 71). The presence of ISAba1 was exclusively detected in isolates carrying the bla OXA-23-like gene. All isolates in which ISAba1 was found upstream of the bla OXA-23-like gene (n = 69) showed resistance to carbapenems, whereas the only isolate in which ISAba1 was not located near the bla OXA-23-like gene was susceptible to carbapenems. The ISAba1 sequence position of another bla OXA-23-like-positive isolate was inconclusive. The isolates exclusively carrying the bla OXA-51-like gene (n = 7) showed susceptibility to carbapenems. CONCLUSIONS: The presence of the ISAba1 sequence upstream of the bla OXA-23-like gene was strongly associated with carbapenem resistance in isolates of the A. calcoaceticus-A. baumannii complex in the hospital center studied.


Subject(s)
Acinetobacter baumannii/drug effects , Acinetobacter calcoaceticus/drug effects , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Carbapenems/pharmacology , DNA, Bacterial/genetics , beta-Lactam Resistance/genetics , Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/genetics , Acinetobacter calcoaceticus/isolation & purification , Bacterial Proteins/metabolism , Brazil , Electrophoresis, Gel, Pulsed-Field , Genotype , Humans , Phenotype , Polymerase Chain Reaction
15.
BMC Infect Dis ; 16: 374, 2016 08 05.
Article in English | MEDLINE | ID: mdl-27496018

ABSTRACT

BACKGROUND: The treatment options for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (MDR Acb) complex are limited, and the optimal treatment has not been established. METHODS: To compare the efficacy of tigecycline-based with sulbactam (or ampicillin/sulbactam)-based therapy for pneumonia involving MDR Acb complex, we conducted a retrospective study comparing 84 tigecycline-treated adult patients during the period August 2007 to March 2010 with 84 sulbactam or ampicillin/sulbactam-treated adult patients during the period September 2004 to July 2007. Both groups had the matched Acute Physiology and Chronic Health Evaluation (APACHE) II score and received treatment for at least 7 days. RESULTS: The mean APACHE II score was 20.1 for both groups. More patients in sulbactam group had ventilator use (89.3 % versus 69.0 %), bilateral pneumonia (79.8 % versus 60.7 %) and combination therapy (84.5 % versus 53.6 %), particularly with carbapenems (71.4 % versus 6.0 %), while more patients in tigecycline group had delayed treatment (41.7 % versus 26.2 %) (P <0.05). At the end of treatment, more patients in sulbactam group had airway MDR Acb complex eradication (63.5 % versus 33.3 %, P <0.05). The clinical resolution rate was 66.7 % for both groups. The mortality rate during treatment was 17.9 % in sulbactam group, and 25.0 % in tigecycline group (P = 0.259). The multivariate analysis showed that bilateral pneumonia was the only independent predictor for mortality during treatment (adjusted odds ratio, 2.717; 95 % confidence interval, 1.015 to 7.272). CONCLUSIONS: Patients treated with either tigecycline-based or sulbactam-based therapy had a similar clinical outcome, but tigecycline group had a lower microbiological eradiation rate.


Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter baumannii , Acinetobacter calcoaceticus , Anti-Bacterial Agents/administration & dosage , Drug Resistance, Multiple, Bacterial , Minocycline/analogs & derivatives , Pneumonia, Bacterial/drug therapy , Sulbactam/administration & dosage , Acinetobacter Infections/microbiology , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/isolation & purification , Adult , Aged , Aged, 80 and over , Carbapenems/therapeutic use , Drug Resistance, Multiple, Bacterial/drug effects , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Minocycline/administration & dosage , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/mortality , Retrospective Studies , Taiwan/epidemiology , Tigecycline , Treatment Outcome
16.
Rev. Soc. Bras. Med. Trop ; 49(4): 433-440, July-Aug. 2016. tab, graf
Article in English | LILACS | ID: lil-792800

ABSTRACT

Abstract: INTRODUCTION: Members of the Acinetobacter genus are key pathogens that cause healthcare-associated infections, and they tend to spread and develop new antibiotic resistance mechanisms. Oxacillinases are primarily responsible for resistance to carbapenem antibiotics. Higher rates of carbapenem hydrolysis might be ascribed to insertion sequences, such as the ISAba1 sequence, near bla OXA genes. The present study examined the occurrence of the genetic elements bla OXA and ISAba1 and their relationship with susceptibility to carbapenems in clinical isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. METHODS: Isolates identified over 6 consecutive years in a general hospital in Joinville, Southern Brazil, were evaluated. The investigation of 5 families of genes encoding oxacillinases and the ISAba1 sequence location relative to bla OXA genes was conducted using polymerase chain reaction. RESULTS: All isolates presented the bla OXA-51-like gene (n = 78), and 91% tested positive for the bla OXA-23-like gene (n = 71). The presence of ISAba1 was exclusively detected in isolates carrying the bla OXA-23-like gene. All isolates in which ISAba1 was found upstream of the bla OXA-23-like gene (n = 69) showed resistance to carbapenems, whereas the only isolate in which ISAba1 was not located near the bla OXA-23-like gene was susceptible to carbapenems. The ISAba1 sequence position of another bla OXA-23-like-positive isolate was inconclusive. The isolates exclusively carrying the bla OXA-51-like gene (n = 7) showed susceptibility to carbapenems. CONCLUSIONS: The presence of the ISAba1 sequence upstream of the bla OXA-23-like gene was strongly associated with carbapenem resistance in isolates of the A. calcoaceticus-A. baumannii complex in the hospital center studied.


Subject(s)
Humans , Bacterial Proteins/genetics , DNA, Bacterial/genetics , Carbapenems/pharmacology , Acinetobacter calcoaceticus/drug effects , beta-Lactam Resistance/genetics , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/pharmacology , Phenotype , Bacterial Proteins/metabolism , Brazil , Acinetobacter Infections/microbiology , Polymerase Chain Reaction , Electrophoresis, Gel, Pulsed-Field , Acinetobacter calcoaceticus/isolation & purification , Acinetobacter calcoaceticus/genetics , Acinetobacter baumannii/isolation & purification , Acinetobacter baumannii/genetics , Genotype
17.
PLoS One ; 11(5): e0156237, 2016.
Article in English | MEDLINE | ID: mdl-27223476

ABSTRACT

Multidrug resistant Acinetobacter baumannii and its closely related species A. pittii and A. nosocomialis, all members of the Acinetobacter calcoaceticus-baumannii (Acb) complex, are a major cause of hospital acquired infection. In the burn wound center of the Queen Astrid military hospital in Brussels, 48 patients were colonized or infected with Acb complex over a 52-month period. We report the molecular epidemiology of these organisms, their clinical impact and infection control measures taken. A representative set of 157 Acb complex isolates was analyzed using repetitive sequence-based PCR (rep-PCR) (DiversiLab) and a multiplex PCR targeting OXA-51-like and OXA-23-like genes. We identified 31 rep-PCR genotypes (strains). Representatives of each rep-type were identified to species by rpoB sequence analysis: 13 types to A. baumannii, 10 to A. pittii, and 3 to A. nosocomialis. It was assumed that isolates that belonged to the same rep-type also belonged to the same species. Thus, 83.4% of all isolates were identified to A. baumannii, 9.6% to A. pittii and 4.5% to A. nosocomialis. We observed 12 extensively drug resistant Acb strains (10 A. baumannii and 2 A. nosocomialis), all carbapenem-non-susceptible/colistin-susceptible and imported into the burn wound center through patients injured in North Africa. The two most prevalent rep-types 12 and 13 harbored an OXA-23-like gene. Multilocus sequence typing allocated them to clonal complex 1 corresponding to EU (international) clone I. Both strains caused consecutive outbreaks, interspersed with periods of apparent eradication. Patients infected with carbapenem resistant A. baumannii were successfully treated with colistin/rifampicin. Extensive infection control measures were required to eradicate the organisms. Acinetobacter infection and colonization was not associated with increased attributable mortality.


Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/isolation & purification , Burns/microbiology , Colistin/therapeutic use , Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Acinetobacter calcoaceticus/genetics , Adolescent , Adult , Africa, Northern/epidemiology , Aged , Aged, 80 and over , Bacterial Typing Techniques , Belgium/epidemiology , Child , Child, Preschool , Drug Resistance, Bacterial , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Multilocus Sequence Typing , Multiplex Polymerase Chain Reaction , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis , Treatment Outcome , Young Adult
18.
Microb Drug Resist ; 22(8): 655-661, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27082787

ABSTRACT

Acinetobacter calcoaceticus-A. baumannii complex (ACB complex) is a nosocomial pathogen. Due to its high ability to develop antibiotic resistance, it has become a problematic challenge in the modern healthcare system. The molecular and genetic mechanisms of gaining multidrug resistance in ACB complex are well known. This study focuses on providing an overview of the antibiotic resistance profiles, genetic similarities and resistotypes, and general characteristics of carbapenem-resistant ACB complex (CRACB) in Bosnia and Herzegovina (BiH). In light of the data collected in this study, together with the already known information concerning antibiotic resistance of ACB complex, we intend to further elucidate the antibiotic therapy for CRACB strain resistotypes in BiH.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Acinetobacter calcoaceticus/genetics , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial/genetics , beta-Lactam Resistance/genetics , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/isolation & purification , Aminoglycosides/pharmacology , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Bosnia and Herzegovina/epidemiology , Carbapenems/pharmacology , Clone Cells , Cross Infection/drug therapy , Cross Infection/microbiology , Humans , Phylogeny , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
19.
Bull Environ Contam Toxicol ; 96(6): 833-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27084098

ABSTRACT

An enrichment culture technique was used for the isolation of bacteria capable of utilizing fipronil as a sole source of carbon and energy. Based on morphological, biochemical characteristics and phylogenetic analysis of 16S rRNA sequence, the bacterial strains were identified as Acinetobacter calcoaceticus and Acinetobacter oleivorans. Biodegradation experiments were conducted in loamy sand soil samples fortified with fipronil (50 µg kg(-1)) and inoculated with Acinetobacter sp. cells (45 × 10(7) CFU mL(-1)) for 90 days. Soil samples were periodically analyzed by gas liquid chromatography equipped with electron capture detector. Biodegradation of fipronil fitted well with the pseudo first-order kinetics, with rate constant value between 0.041 and 0.051 days(-1). In pot experiments, fipronil and its metabolites fipronil sulfide, fipronil sulfone and fipronil amide were found below quantifiable limit in soil and root, shoot and leaves of Zea mays. These results demonstrated that A. calcoaceticus and A. oleivorans may serve as promising strains in the bioremediation of fipronil-contaminated soils.


Subject(s)
Acinetobacter calcoaceticus/isolation & purification , Pyrazoles/chemistry , Zea mays/microbiology , Acinetobacter calcoaceticus/metabolism , Biodegradation, Environmental , Chromatography, Gas , Insecticides/chemistry , Phylogeny , Plant Roots/microbiology , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/isolation & purification , Soil/chemistry , Soil Microbiology , Soil Pollutants/analysis
20.
Microb Drug Resist ; 22(8): 627-637, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27003287

ABSTRACT

In addition to intrinsic resistance in Acinetobacter baumannii, many different types of acquired resistance mechanisms have been reported, including the presence of VIM and IMP metallo ß-lactamases and also of blaOXA-23-like and blaOXA-58-like enzymes. In the Kurdistan region of Iraq, the multiresistant A. baumannii-calcoaceticus complex is prevalent. We characterized the different mechanisms of resistance present in clinical isolates collected from different wards and different hospitals from the Kurdistan region. One hundred twenty clinical nonduplicate A. baumannii-calcoaceticus complex isolates were collected from four hospitals between January 2012 and October 2013. The identification of the isolates was confirmed by MALDI-TOF. The susceptibility to different antibiotics was determined by disk diffusion and analyzed in accordance to EUCAST guidelines. By PCR, the presence of blaOXA-51-like, blaOXA-23-like, blaOXA-24-like, and blaOXA-58-like genes was determined as well as the presence of the insertion element ISAba1. Clonal diversity was analyzed by pulsed-field gel electrophoresis (PFGE) using the restriction enzyme ApaI and, in addition, multilocus sequence typing (MLST) was performed on a selected subset of 15 isolates. All 120 A. baumannii isolates harbored blaOXA-51-like genes. One hundred one out of 110 (92%) imipenem (IMP)-resistant A. baumannii-calcoaceticus complex isolates additionally carried the blaOXA-23-like gene and four isolates (3%) were positive for blaOXA-24-like. All 101 blaOXA-23-like-positive isolates had the ISAba1 insertion sequence, 1,600 bp upstream of the blaOXA-23-like gene. The blaOXA-58-like gene was not detected in any of the 110 IMP-resistant strains. Eight different PFGE clusters were identified and distributed over the different hospitals. MLST analysis performed on a subset of 15 representative isolates revealed the presence of the international clone ST2 (Pasteur). Besides ST2 (Pasteur), also many other STs (Pasteur) were encountered such as ST136, ST94, ST623, ST792, and ST793, all carrying the blaOXA-23 gene. In clinical A. baumannii-calcoaceticus complex isolates from Kurdistan-Iraq, the blaOXA-23 gene in combination with the upstream ISAba1 insertion element is largely responsible for carbapenem resistance. Several small clusters of identical genotypes were found from patients admitted to the same ward and during overlapping time periods, suggesting transmission within the hospital. Identification of source(s) and limiting the transmission of these strains to patients needs to be prioritized.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter baumannii/genetics , Acinetobacter calcoaceticus/genetics , Bacterial Proteins/genetics , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial/genetics , Gene Expression Regulation, Bacterial , beta-Lactamases/genetics , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/isolation & purification , Adolescent , Adult , Aged , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/classification , Bacterial Proteins/metabolism , Child , Child, Preschool , Clone Cells , Cross Infection/drug therapy , Cross Infection/microbiology , Disk Diffusion Antimicrobial Tests , Electrophoresis, Gel, Pulsed-Field , Female , Humans , Imipenem/pharmacology , Iraq/epidemiology , Male , Middle Aged , Multilocus Sequence Typing , Phylogeny , Plasmids/chemistry , Plasmids/metabolism , Polymerase Chain Reaction , Prevalence , beta-Lactamases/classification , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...